Lunken Lab Biobank, Canada

Certification Status: Checklist Required
Registration Status: Completed

Objective: The biobank is designed to support translational and clinical research focused on inflammatory bowel disease (IBD). It enables the investigation of microbiome-related aspects of IBD, including disease progression, treatment response, and biomarker discovery. To enable investigation of these aspects, the biobank will collect and store de-identified fecal, mucosal, and tissue samples from IBD patients during different phases of their disease as well as non-IBD controls. The purpose of the biobank is to create a comprehensive resource that reflects the IBD patient population in British Columbia, Canada. To achieve this, the target enrollment may include patients of varying age groups, genders, ethnicities, and disease stages (active, quiescent, control).

Registered Biobank Name Lunken Lab Biobank
Biobank Leader Gurpreet Kaur
Country Canada
Email for biobank inquiries
Principal Investigator Dr. Genelle Lunken
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: